Light Mode
$69.90 ↑ +0.17 (+0.24%) Trading Up from the previous close of $69.73
-31.53 (-31.14%) / 6M
Momentum, market sentiment, and recent alerts
TMDX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -46.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.